Jay K Kolls Selected Research

Candidiasis (Moniliasis)

1/2020	Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.
1/2019	Diagnosis of Fungal Infections. A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline.
1/2018	Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection.
11/2016	IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.
11/2016	The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney.
1/2012	The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jay K Kolls Research Topics

Disease

83	Infections 05/2024 - 01/2002
61	Inflammation (Inflammations) 04/2024 - 11/2002
23	Asthma (Bronchial Asthma) 05/2024 - 09/2008
23	Pneumonia (Pneumonitis) 12/2023 - 11/2002
18	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 01/2005
17	Neoplasms (Cancer) 12/2023 - 09/2003
12	Human Influenza (Influenza) 12/2023 - 10/2009
11	COVID-19 05/2024 - 01/2021
11	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2004
10	Pneumocystis Infections 01/2022 - 09/2002
7	Arthritis (Polyarthritis) 12/2011 - 03/2003
6	Coinfection 01/2021 - 01/2006
6	Candidiasis (Moniliasis) 01/2020 - 01/2012
5	Virus Diseases (Viral Diseases) 12/2023 - 10/2009
5	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 09/2002
5	Lung Diseases (Lung Disease) 01/2019 - 02/2007
5	Respiratory Syncytial Virus Infections 01/2017 - 09/2005
4	Bacterial Pneumonia 01/2021 - 03/2008
4	Opportunistic Infections (Opportunistic Infection) 01/2020 - 12/2005
4	Melanoma (Melanoma, Malignant) 06/2017 - 09/2003
4	Lung Injury 01/2017 - 02/2006
4	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2006
3	Dysbiosis 12/2023 - 03/2016
3	Disease Progression 01/2023 - 01/2014
3	Liver Diseases (Liver Disease) 01/2023 - 09/2005
3	Critical Illness (Critically Ill) 01/2020 - 01/2006
3	Hepatitis 11/2019 - 12/2008
3	Fibrosis (Cirrhosis) 11/2019 - 09/2008
3	Pneumococcal Infections 11/2019 - 05/2015
3	Mycoses (Diseases, Fungus) 01/2019 - 09/2013
3	Tuberculosis (Tuberculoses) 10/2017 - 11/2011
3	Immune Reconstitution Inflammatory Syndrome 01/2017 - 11/2002
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2016 - 03/2009
3	Communicable Diseases (Infectious Diseases) 06/2014 - 07/2013
3	Respiratory Hypersensitivity 01/2014 - 09/2008
3	Weight Loss (Weight Reduction) 01/2013 - 05/2006
3	Cryptococcosis 12/2012 - 12/2010
3	Rheumatoid Arthritis 04/2010 - 09/2005
3	Experimental Arthritis 04/2010 - 03/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2009 - 04/2007
2	Adenocarcinoma 12/2023 - 09/2003
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2023 - 01/2023
2	HIV Infections (HIV Infection) 08/2023 - 11/2005
2	Atherosclerosis 01/2023 - 04/2010
2	Idiopathic Pulmonary Fibrosis 11/2022 - 09/2019
2	Colitis 01/2021 - 05/2006

Drug/Important Bio-Agent (IBA)

77	Interleukin-17 (Interleukin 17)IBA 12/2023 - 01/2003
45	CytokinesIBA 05/2024 - 11/2002
22	Interleukin-22 (IL-22)IBA 07/2022 - 03/2008
16	Interleukin-17 ReceptorsIBA 12/2023 - 01/2005
14	AntigensIBA 01/2023 - 12/2005
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2006
13	Interleukin-23 (Interleukin 23)IBA 07/2022 - 05/2003
11	VaccinesIBA 12/2016 - 12/2005
9	Interferon-gamma (Interferon, gamma)IBA 12/2023 - 09/2002
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2002
9	InterleukinsIBA 01/2021 - 04/2010
8	ChemokinesIBA 01/2021 - 02/2007
7	RNA (Ribonucleic Acid)IBA 10/2023 - 07/2015
7	Ethanol (Ethyl Alcohol)IBA 01/2023 - 03/2003
7	LigandsIBA 11/2019 - 03/2003
7	Interleukin-6 (Interleukin 6)IBA 11/2019 - 05/2006
7	Interleukin-13IBA 05/2015 - 05/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2002
6	AllergensIBA 05/2024 - 10/2009
6	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2023 - 02/2006
6	Immunoglobulin G (IgG)IBA 10/2023 - 05/2006
5	Antiviral Agents (Antivirals)IBA 05/2024 - 08/2014
5	OvalbuminIBA 09/2014 - 01/2010
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2014 - 05/2002
4	LipopolysaccharidesIBA 01/2024 - 04/2002
4	Interleukin-1 (Interleukin 1)IBA 07/2022 - 03/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2005
4	Estrogens (Estrogen)FDA Link 01/2021 - 09/2005
4	interleukin-22 receptor (IL-22R)IBA 11/2019 - 10/2010
4	Messenger RNA (mRNA)IBA 01/2019 - 01/2002
4	SteroidsIBA 01/2015 - 09/2008
3	Peptides (Polypeptides)IBA 05/2024 - 03/2013
3	Immunoglobulin E (IgE)IBA 05/2024 - 01/2014
3	CollagenIBA 12/2023 - 03/2003
3	Bicarbonates (Hydrogen Carbonate)IBA 11/2023 - 02/2009
3	Antimicrobial PeptidesIBA 01/2023 - 03/2014
3	InterferonsIBA 01/2021 - 01/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2015
3	Cholecalciferol (Vitamin D3)FDA Link 01/2020 - 09/2010
3	AntibodiesIBA 01/2019 - 12/2010
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 04/2006
3	Biomarkers (Surrogate Marker)IBA 07/2015 - 04/2012
3	Interleukin-10 (Interleukin 10)IBA 02/2015 - 11/2002
3	Toll-Like Receptor 4IBA 05/2014 - 05/2003
3	Chemotactic FactorsIBA 01/2014 - 08/2006
3	Interleukin-23 Subunit p19IBA 12/2009 - 07/2005
2	Superoxides (Superoxide)IBA 01/2024 - 05/2002
2	ChloridesIBA 11/2023 - 01/2023
2	InflammasomesIBA 08/2023 - 01/2017
2	EnzymesIBA 01/2023 - 01/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2005
5	Immunotherapy 01/2020 - 02/2007
4	Highly Active Antiretroviral Therapy (HAART) 01/2006 - 11/2002